BRVE - Braveheart Bio, Inc.
Price:
--
--
|
PRICE TARGET:
$45.25
DETAILS
HIGH:
$48.00
LOW:
$40.00
MEDIAN:
$46.50
CONSENSUS:
$45.25
UPSIDE:
93.62%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-08-07 | Agarwala Vineeta | director | ? | -- | -- | -- |
| 2026-08-07 | AH Bio Fund IV, L.P. | 10 percent owner | C-Conversion | 40,000,000 | -- | -- |
| 2026-08-07 | Chimovits Erez | director, 10 percent owner: | BUY | 273,333 | $18.00 | $4.9M |
| 2026-08-07 | Chimovits Erez | director, 10 percent owner: | C-Conversion | 40,000,000 | -- | -- |
| 2026-08-07 | ORBIMED ADVISORS LLC | director, 10 percent owner: | C-Conversion | 9,132,420 | -- | -- |
| 2026-08-07 | ORBIMED ADVISORS LLC | director, 10 percent owner: | BUY | 1,666,667 | $18.00 | $30.0M |
| 2026-08-07 | AH Bio Fund IV, L.P. | 10 percent owner | BUY | 1,100,000 | $18.00 | $19.8M |
| 2026-08-07 | ORBIMED ADVISORS LLC | director, 10 percent owner: | BUY | 273,333 | $18.00 | $4.9M |
| 2026-08-07 | ORBIMED ADVISORS LLC | director, 10 percent owner: | C-Conversion | 40,000,000 | -- | -- |
| 2026-08-07 | AH Bio Fund IV, L.P. | 10 percent owner | C-Conversion | 9,132,420 | -- | -- |
| 2026-08-07 | Chimovits Erez | director, 10 percent owner: | C-Conversion | 9,132,420 | -- | -- |
| 2026-08-07 | Chimovits Erez | director, 10 percent owner: | BUY | 1,666,667 | $18.00 | $30.0M |
| 2026-08-07 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10 percent owner | C-Conversion | 32,500,000 | -- | -- |
| 2026-08-07 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10 percent owner | C-Conversion | 7,420,091 | -- | -- |
| 2026-08-07 | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10 percent owner | C-Conversion | 9,132,420 | -- | -- |
| 2026-08-07 | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10 percent owner | BUY | 1,680,000 | $18.00 | $30.2M |
| 2026-08-07 | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10 percent owner | C-Conversion | 35,000,000 | -- | -- |
| 2026-08-07 | Viehbacher Christopher | director | BUY | 83,333 | $18.00 | $1.5M |
| 2026-08-07 | Murdoch Travis | director, officer: CEO and President | BUY | 83,333 | $18.00 | $1.5M |
| 2026-08-07 | Lubner David Charles | director | BUY | 55,555 | $18.00 | $1000K |
| 2026-08-05 | Lubner David Charles | director | A-Award | 60,000 | $18.00 | $1.1M |
| 2026-08-05 | Murdoch Travis | director, officer: CEO and President | A-Award | 550,000 | $19.80 | $10.9M |
| 2026-08-07 | Rickey James Paul | officer: Chief Financial Officer | BUY | 27,777 | $18.00 | $500K |
| 2026-08-05 | Lohoff Tim | director | A-Award | 30,000 | $18.00 | $540K |
| 2026-08-07 | Malek David I | director | BUY | 4,166 | $18.00 | $75K |